该公司主要从事骨科和脊柱生物学领域。它提供固定系统和生物学产品,旨在治疗脊柱和骨科疾病。
排他性优势:
1. 拥有强大的研发能力,能不断开发和推出创新产品,如新的固定系统和生物学产品。
2. 构建了一个互补的产品组合,包括固定和生物学解决方案,能...查看全文
$Xtant Medical Holdings, Inc.(XTNT)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-05-23 AccNo: 0000000000-18-015998 Size: 46 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ CORRESP [Cover] - Correspondence Filed: 2018-05-30 AccNo: 0001144204-18-031675 Size: 29 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-05-23 AccNo: 0000000000-18-015998 Size: 46 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ DEFR14A - Revised definitive proxy soliciting materials Filed: 2018-06-26 AccNo: 0001493152-18-009212 Size: 1 MB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ DEF 14A - Other definitive proxy statements Filed: 2018-06-26 AccNo: 0001493152-18-009197 Size: 886 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 8-K - Current report Filed: 2018-06-19 AccNo: 0001493152-18-008885 Size: 58 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ EFFECT - Notice of Effectiveness Filed: 2018-06-04 AccNo: 9999999995-18-001404 Size: 1 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-06-04 AccNo: 0001144204-18-032695 Size: 255 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-06-04 AccNo: 0001144204-18-032695 Size: 255 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2018-05-30 AccNo: 0001144204-18-031665 Size: 434 KB 网页链接